Medicaid spending Medicaid programs cover some GLP-1 drugs to treat obesity in at least 13 other states: California, Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, New Hampshire, Pennsylvania, Rhode Island, South Carolina, Virginia and Wisconsin
This distinguishes 5-amino-1mq from compounds like cagrilintide or tirzepatide that work primarily through appetite suppression
Bypassing the gut barrier, IV administration allows for maximum absorption of the nutrients
It is crucial to consider these limitations when interpreting the findings of our research and to encourage further investigations, including clinical trials and self-testing cohort data of clinical dosing information, to validate and expand upon our observations
Regulatory bodies worldwide are continuously monitoring and updating guidance to keep patients safe